By Theresa Curry Early next year, biopharmaceutical company Priovant Therapeutics, an affiliate of Roivant Sciences, plans to file for FDA approval of brepocitinib. If approved, the drug could become the…
Continue Reading
Because no one should face myositis alone.Give Now!
By Theresa Curry Early next year, biopharmaceutical company Priovant Therapeutics, an affiliate of Roivant Sciences, plans to file for FDA approval of brepocitinib. If approved, the drug could become the…
Continue Reading
TeriAnn was in the best shape of her life in her early 40’s, so she was surprised and disturbed to find herself on a plane unable to lift her carry-on…
Continue Reading
Columbia, MD — December 3, 2025 — The Myositis Association (TMA) is proud to announce a new research partnership with the Muscular Dystrophy Association (MDA) to co-fund a groundbreaking study…
Continue Reading
By Begum Horuluoglu, PhD Thanks to the generous support of The Myositis Association (TMA), I have been able to pursue groundbreaking research into the immunological mechanisms underlying idiopathic inflammatory myopathies,…
Continue Reading
By Dorothy Vetrano The holiday season is upon us! It’s a time to celebrate with family and friends, enjoy home-cooked foods, and give thanks for all the blessings in our…
Continue Reading